ATP6V0C (ATPase H+ transporting V0 subunit c) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: ATP6V0C (ATPase H+ transporting V0 subunit c) Homo sapiens
Analyze
Symbol: ATP6V0C
Name: ATPase H+ transporting V0 subunit c
RGD ID: 731892
HGNC Page HGNC:855
Description: Enables ubiquitin protein ligase binding activity. Involved in positive regulation of Wnt signaling pathway. Located in extracellular exosome; focal adhesion; and lysosomal membrane. Part of membrane. Implicated in early-onset epilepsy 3 and thyroid gland carcinoma.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: ATP6C; ATP6L; ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c; ATPL; EPEO3; H(+)-transporting two-sector ATPase, 16 kDa subunit; V-ATPase 16 kDa proteolipid subunit; V-ATPase 16 kDa proteolipid subunit c; V-ATPase subunit c; V-type proton ATPase 16 kDa proteolipid subunit; V-type proton ATPase 16 kDa proteolipid subunit c; vacuolar ATP synthase 16 kDa proteolipid subunit; vacuolar H+ ATPase proton channel subunit; vacuolar proton pump 16 kDa proteolipid subunit; vacuolar proton pump 16 kDa proteolipid subunit c; vacuolar proton pump, 16 kDa subunit; VATL; Vma3; VPPC
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Orthologs
More Info more info ...
Related Pseudogenes: ATP6V0CP1   ATP6V0CP2   ATP6V0CP3   ATP6V0CP4  
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38162,513,726 - 2,520,218 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl162,513,952 - 2,520,218 (+)EnsemblGRCh38hg38GRCh38
GRCh37162,563,727 - 2,570,219 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36162,503,954 - 2,510,220 (+)NCBINCBI36Build 36hg18NCBI36
Build 34162,503,953 - 2,510,219NCBI
Celera162,755,525 - 2,785,155 (+)NCBICelera
Cytogenetic Map16p13.3NCBI
HuRef162,489,699 - 2,496,194 (+)NCBIHuRef
CHM1_1162,563,664 - 2,570,161 (+)NCBICHM1_1
T2T-CHM13v2.0162,535,856 - 2,542,340 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(-)-epigallocatechin 3-gallate  (EXP)
1,2-dimethylhydrazine  (ISO)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (ISO)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4-dinitrotoluene  (ISO)
2-hydroxypropanoic acid  (EXP)
4,4'-sulfonyldiphenol  (ISO)
5-azacytidine  (EXP)
aflatoxin B1  (EXP)
all-trans-retinoic acid  (EXP,ISO)
ammonium chloride  (ISO)
amphetamine  (ISO)
antirheumatic drug  (EXP)
aristolochic acid A  (EXP)
arsane  (EXP)
arsenic atom  (EXP)
arsenite(3-)  (EXP)
benzo[a]pyrene  (ISO)
bexarotene  (ISO)
bisphenol A  (ISO)
Bisphenol B  (EXP)
bisphenol F  (EXP,ISO)
bucladesine  (EXP)
butan-1-ol  (EXP)
cadmium dichloride  (ISO)
caffeine  (ISO)
carbon nanotube  (ISO)
carmustine  (EXP)
choline  (ISO)
clobetasol  (ISO)
dextran sulfate  (ISO)
dichlorine  (ISO)
doxorubicin  (EXP)
epoxiconazole  (ISO)
ethanol  (ISO)
Evodiamine  (ISO)
flutamide  (ISO)
folic acid  (ISO)
fumonisin B1  (ISO)
gentamycin  (ISO)
hexadecanoic acid  (EXP)
isotretinoin  (EXP)
ivermectin  (EXP)
L-methionine  (ISO)
Licochalcone B  (EXP)
Maduramicin  (ISO)
maneb  (ISO)
medroxyprogesterone acetate  (EXP)
miconazole  (ISO)
ochratoxin A  (EXP)
ozone  (ISO)
paracetamol  (ISO)
paraquat  (ISO)
phenylpropanolamine  (ISO)
potassium chromate  (EXP)
rac-lactic acid  (EXP)
reactive oxygen species  (ISO)
rotenone  (EXP)
sodium arsenate  (ISO)
sodium arsenite  (EXP)
sodium fluoride  (ISO)
testosterone  (ISO)
titanium dioxide  (ISO)
triphenyl phosphate  (EXP)
Triptolide  (ISO)
urethane  (EXP)
valproic acid  (EXP)
vanadium atom  (EXP)
vanadium(0)  (EXP)
vinclozolin  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Molecular Pathway Annotations     Click to see Annotation Detail View
References

References - curated
# Reference Title Reference Citation
1. PFKFB2 Promoter Hypomethylation as Recurrence Predictive Marker in Well-Differentiated Thyroid Carcinomas. Camargo Barros-Filho M, etal., Int J Mol Sci. 2019 Mar 16;20(6). pii: ijms20061334. doi: 10.3390/ijms20061334.
2. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
3. KEGG: Kyoto Encyclopedia of Genes and Genomes KEGG
4. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
5. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:1334459   PMID:1532310   PMID:1709739   PMID:2874839   PMID:7636472   PMID:8250920   PMID:8741845   PMID:9210392   PMID:9442887   PMID:10221984   PMID:10224039   PMID:10340843  
PMID:10440860   PMID:11543633   PMID:11836511   PMID:12438748   PMID:12477932   PMID:12788495   PMID:14580332   PMID:14597263   PMID:15466867   PMID:15489334   PMID:16169070   PMID:16415858  
PMID:16751776   PMID:17662945   PMID:17897319   PMID:18298843   PMID:18854154   PMID:19056867   PMID:19058789   PMID:19299075   PMID:19875448   PMID:20093472   PMID:21087195   PMID:21423176  
PMID:21433058   PMID:21516116   PMID:21873635   PMID:21988832   PMID:22829766   PMID:22982048   PMID:22991218   PMID:24166050   PMID:24254321   PMID:24385903   PMID:24623722   PMID:24623842  
PMID:24695574   PMID:25416956   PMID:26110566   PMID:26186194   PMID:26264242   PMID:26638075   PMID:28298427   PMID:28514442   PMID:28700943   PMID:29138865   PMID:31515488   PMID:31536960  
PMID:31554233   PMID:31840304   PMID:31871319   PMID:31980649   PMID:32001091   PMID:32291285   PMID:32296183   PMID:32513696   PMID:32814053   PMID:33065002   PMID:33144569   PMID:33961781  
PMID:34373451   PMID:35271311   PMID:35561222   PMID:36074901   PMID:36476874   PMID:36736316   PMID:36949045   PMID:37161035   PMID:38270169   PMID:38481802  


Genomics

Comparative Map Data
ATP6V0C
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38162,513,726 - 2,520,218 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl162,513,952 - 2,520,218 (+)EnsemblGRCh38hg38GRCh38
GRCh37162,563,727 - 2,570,219 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36162,503,954 - 2,510,220 (+)NCBINCBI36Build 36hg18NCBI36
Build 34162,503,953 - 2,510,219NCBI
Celera162,755,525 - 2,785,155 (+)NCBICelera
Cytogenetic Map16p13.3NCBI
HuRef162,489,699 - 2,496,194 (+)NCBIHuRef
CHM1_1162,563,664 - 2,570,161 (+)NCBICHM1_1
T2T-CHM13v2.0162,535,856 - 2,542,340 (+)NCBIT2T-CHM13v2.0
Atp6v0c
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391724,382,839 - 24,388,652 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1724,382,840 - 24,388,676 (-)EnsemblGRCm39 Ensembl
GRCm381724,163,865 - 24,169,678 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1724,163,866 - 24,169,702 (-)EnsemblGRCm38mm10GRCm38
MGSCv371724,300,833 - 24,306,374 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361723,891,488 - 23,897,029 (-)NCBIMGSCv36mm8
Celera1724,669,200 - 24,674,661 (-)NCBICelera
Cytogenetic Map17A3.3NCBI
cM Map1712.29NCBI
Atp6v0c
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81013,700,764 - 13,707,147 (-)NCBIGRCr8
mRatBN7.21013,196,204 - 13,202,580 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1013,196,204 - 13,201,500 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1017,941,023 - 17,946,085 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01017,429,860 - 17,434,922 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01012,928,324 - 12,933,402 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01013,537,031 - 13,543,407 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1013,537,033 - 13,542,077 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01013,352,991 - 13,359,367 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41013,415,671 - 13,420,715 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11013,415,670 - 13,420,715 (-)NCBI
Celera1012,882,252 - 12,887,296 (-)NCBICelera
Cytogenetic Map10q12NCBI
Atp6v0c
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495544214,791,795 - 14,798,066 (-)EnsemblChiLan1.0
ChiLan1.0NW_00495544214,791,795 - 14,798,066 (-)NCBIChiLan1.0ChiLan1.0
ATP6V0C
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v2183,015,432 - 3,021,889 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan1166,796,438 - 6,802,895 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0161,370,460 - 1,376,775 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1162,613,096 - 2,619,204 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl162,613,096 - 2,619,204 (+)Ensemblpanpan1.1panPan2
ATP6V0C
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1638,519,869 - 38,525,217 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl638,520,765 - 38,525,062 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha639,758,250 - 39,763,598 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0638,829,102 - 38,834,450 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl638,829,102 - 38,834,443 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1638,514,259 - 38,519,609 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0638,486,868 - 38,492,219 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0638,962,951 - 38,968,303 (-)NCBIUU_Cfam_GSD_1.0
Atp6v0c
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024409344105,167,247 - 105,173,070 (+)NCBIHiC_Itri_2
SpeTri2.0NW_0049366941,536,393 - 1,542,218 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
ATP6V0C
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1339,532,707 - 39,538,704 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2342,700,733 - 42,706,549 (+)NCBISscrofa10.2Sscrofa10.2susScr3
ATP6V0C
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.152,387,891 - 2,394,111 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl52,387,812 - 2,394,180 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366606828,630,936 - 28,637,307 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Atp6v0c
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_004624824267,102 - 272,893 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_004624824267,102 - 272,893 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in ATP6V0C
25 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 16p13.3(chr16:2326840-3487106)x3 copy number gain See cases [RCV000052394] Chr16:2326840..3487106 [GRCh38]
Chr16:2376841..3537106 [GRCh37]
Chr16:2316842..3477107 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3-13.13(chr16:23141-11296695)x3 copy number gain See cases [RCV000052367] Chr16:23141..11296695 [GRCh38]
Chr16:73141..11390552 [GRCh37]
Chr16:13141..11298053 [NCBI36]
Chr16:16p13.3-13.13
pathogenic
GRCh38/hg38 16p13.3(chr16:2494804-3246579)x1 copy number loss See cases [RCV000053269] Chr16:2494804..3246579 [GRCh38]
Chr16:2544805..3296579 [GRCh37]
Chr16:2484806..3236580 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:2365461-2532960)x1 copy number loss See cases [RCV000138952] Chr16:2365461..2532960 [GRCh38]
Chr16:2415462..2582961 [GRCh37]
Chr16:2355463..2522962 [NCBI36]
Chr16:16p13.3
pathogenic|uncertain significance
GRCh38/hg38 16p13.3(chr16:2406643-2782411)x1 copy number loss See cases [RCV000141237] Chr16:2406643..2782411 [GRCh38]
Chr16:2456644..2832412 [GRCh37]
Chr16:2396645..2772413 [NCBI36]
Chr16:16p13.3
likely pathogenic
GRCh38/hg38 16p13.3(chr16:2365461-2764284)x1 copy number loss See cases [RCV000142469] Chr16:2365461..2764284 [GRCh38]
Chr16:2415462..2814285 [GRCh37]
Chr16:2355463..2754286 [NCBI36]
Chr16:16p13.3
uncertain significance
GRCh38/hg38 16p13.3(chr16:29941-2560460)x3 copy number gain See cases [RCV000052368] Chr16:29941..2560460 [GRCh38]
Chr16:79941..2610461 [GRCh37]
Chr16:19941..2550462 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:46766-3214623)x3 copy number gain See cases [RCV000052370] Chr16:46766..3214623 [GRCh38]
Chr16:96766..3264623 [GRCh37]
Chr16:36766..3204624 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3-13.13(chr16:46766-11525516)x3 copy number gain See cases [RCV000133780] Chr16:46766..11525516 [GRCh38]
Chr16:96766..11619372 [GRCh37]
Chr16:36766..11526873 [NCBI36]
Chr16:16p13.3-13.13
pathogenic
GRCh38/hg38 16p13.3(chr16:46766-4247185)x3 copy number gain See cases [RCV000136687] Chr16:46766..4247185 [GRCh38]
Chr16:96766..4297186 [GRCh37]
Chr16:36766..4237187 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3-13.12(chr16:43732-13326806)x3 copy number gain See cases [RCV000139166] Chr16:43732..13326806 [GRCh38]
Chr16:93732..13420663 [GRCh37]
Chr16:33732..13328164 [NCBI36]
Chr16:16p13.3-13.12
pathogenic
GRCh38/hg38 16p13.3(chr16:2304443-2676863)x1 copy number loss See cases [RCV000142177] Chr16:2304443..2676863 [GRCh38]
Chr16:2354444..2726864 [GRCh37]
Chr16:2294445..2666865 [NCBI36]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3 copy number gain Breast ductal adenocarcinoma [RCV000207053] Chr16:1279324..31926800 [GRCh37]
Chr16:16p13.3-11.2
uncertain significance
GRCh37/hg19 16p13.3(chr16:2188712-2580690)x4 copy number gain See cases [RCV000240524] Chr16:2188712..2580690 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 copy number gain See cases [RCV000446684] Chr16:69193..90274381 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-13.2(chr16:78801-9169448) copy number gain See cases [RCV000446555] Chr16:78801..9169448 [GRCh37]
Chr16:16p13.3-13.2
pathogenic
GRCh37/hg19 16p13.3(chr16:97133-5122974)x3 copy number gain See cases [RCV000445663] Chr16:97133..5122974 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:643377-3125125)x3 copy number gain See cases [RCV000510815] Chr16:643377..3125125 [GRCh37]
Chr16:16p13.3
uncertain significance
maternal UPD(16p) complex Hemimegalencephaly [RCV000494707] Chr16:1280042..33710558 [GRCh37]
Chr16:16p13.3-11.2
pathogenic
GRCh37/hg19 16p13.3-12.2(chr16:85880-22442007)x3 copy number gain See cases [RCV000511360] Chr16:85880..22442007 [GRCh37]
Chr16:16p13.3-12.2
pathogenic
GRCh38/hg38 16p13.3-13.11(chr16:666662-15743104)x3 copy number gain See cases [RCV000143710] Chr16:666662..15743104 [GRCh38]
Chr16:716662..15836961 [GRCh37]
Chr16:656663..15744462 [NCBI36]
Chr16:16p13.3-13.11
pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3 copy number gain See cases [RCV000203445] Chr16:102839..28327676 [GRCh37]
Chr16:16p13.3-11.2
pathogenic
GRCh37/hg19 16p13.3-12.3(chr16:1274615-19073133)x3 copy number gain Breast ductal adenocarcinoma [RCV000207326] Chr16:1274615..19073133 [GRCh37]
Chr16:16p13.3-12.3
uncertain significance
GRCh37/hg19 16p13.3-12.3(chr16:85880-19806921)x3 copy number gain See cases [RCV000512194] Chr16:85880..19806921 [GRCh37]
Chr16:16p13.3-12.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1505184-4415346)x3 copy number gain not provided [RCV000683745] Chr16:1505184..4415346 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 copy number gain not provided [RCV000738918] Chr16:88165..90274695 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 copy number gain See cases [RCV000512138] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-13.2(chr16:85880-9883129)x3 copy number gain See cases [RCV000510698] Chr16:85880..9883129 [GRCh37]
Chr16:16p13.3-13.2
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) copy number gain See cases [RCV000511296] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-13.13(chr16:85880-11209288)x3 copy number gain not provided [RCV000683743] Chr16:85880..11209288 [GRCh37]
Chr16:16p13.3-13.13
pathogenic
GRCh37/hg19 16p13.3(chr16:85880-3216551)x3 copy number gain not provided [RCV000683742] Chr16:85880..3216551 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 copy number gain not provided [RCV000738915] Chr16:61451..90294632 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3(chr16:2070917-2592737)x3 copy number gain not provided [RCV000845878] Chr16:2070917..2592737 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:2527176-2581549)x1 copy number loss not provided [RCV000849402] Chr16:2527176..2581549 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:1942430-2653144)x3 copy number gain not provided [RCV002473837] Chr16:1942430..2653144 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:84485-5251013)x3 copy number gain not provided [RCV001537890] Chr16:84485..5251013 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1847662-2653144) copy number gain not specified [RCV002052502] Chr16:1847662..2653144 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_256302)_(5971108_?)dup duplication Familial Mediterranean fever [RCV001877532]|Fanconi anemia [RCV001877533]|not provided [RCV001877531] Chr16:256302..5971108 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.404T>C (p.Leu135Pro) single nucleotide variant not provided [RCV002291390] Chr16:2519681 [GRCh38]
Chr16:2569682 [GRCh37]
Chr16:16p13.3
likely pathogenic
GRCh37/hg19 16p13.3(chr16:111043-6627459)x3 copy number gain See cases [RCV002292215] Chr16:111043..6627459 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.445G>A (p.Ala149Thr) single nucleotide variant not provided [RCV002306034] Chr16:2519722 [GRCh38]
Chr16:2569723 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.79G>A (p.Ala27Thr) single nucleotide variant not provided [RCV002308963] Chr16:2514182 [GRCh38]
Chr16:2564183 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.295G>A (p.Val99Met) single nucleotide variant not provided [RCV002462369] Chr16:2519572 [GRCh38]
Chr16:2569573 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.294dup (p.Val99fs) duplication not provided [RCV003222851] Chr16:2519570..2519571 [GRCh38]
Chr16:2569571..2569572 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.424G>T (p.Gly142Cys) single nucleotide variant See cases [RCV003225710] Chr16:2519701 [GRCh38]
Chr16:2569702 [GRCh37]
Chr16:16p13.3
likely pathogenic
GRCh37/hg19 16p13.3(chr16:2564105-2647768)x1 copy number loss not provided [RCV003222892] Chr16:2564105..2647768 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.283G>C (p.Ala95Pro) single nucleotide variant EPILEPSY, EARLY-ONSET, 3, WITH DEVELOPMENTAL DELAY [RCV003320496] Chr16:2519560 [GRCh38]
Chr16:2569561 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.64G>A (p.Ala22Thr) single nucleotide variant Epilepsy, early-onset, 3, with or without developmental delay [RCV003320499] Chr16:2514167 [GRCh38]
Chr16:2564168 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.361_373del (p.Thr121fs) deletion Epilepsy, early-onset, 3, with or without developmental delay [RCV003320500] Chr16:2519636..2519648 [GRCh38]
Chr16:2569637..2569649 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.134_135del (p.Ser45fs) deletion EPILEPSY, EARLY-ONSET, 3, WITH DEVELOPMENTAL DELAY [RCV003320494] Chr16:2519271..2519272 [GRCh38]
Chr16:2569272..2569273 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.448C>T (p.Leu150Phe) single nucleotide variant EPILEPSY, EARLY-ONSET, 3, WITH DEVELOPMENTAL DELAY [RCV003320498]|not provided [RCV004723264] Chr16:2519725 [GRCh38]
Chr16:2569726 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:2480793-2590012)x1 copy number loss not provided [RCV003483257] Chr16:2480793..2590012 [GRCh37]
Chr16:16p13.3
likely pathogenic
GRCh37/hg19 16p13.3(chr16:1054247-2592737)x3 copy number gain not provided [RCV003485080] Chr16:1054247..2592737 [GRCh37]
Chr16:16p13.3
likely pathogenic
NM_001694.4(ATP6V0C):c.283G>A (p.Ala95Thr) single nucleotide variant Childhood-onset epilepsy syndrome [RCV004527566] Chr16:2519560 [GRCh38]
Chr16:2569561 [GRCh37]
Chr16:16p13.3
likely pathogenic
NM_001694.4(ATP6V0C):c.395T>A (p.Ile132Asn) single nucleotide variant not provided [RCV004592259] Chr16:2519672 [GRCh38]
Chr16:2569673 [GRCh37]
Chr16:16p13.3
likely pathogenic
NC_000016.9:g.(?_339420)_(3767509_?)dup duplication Epilepsy [RCV004581460]|Idiopathic generalized epilepsy [RCV004581461] Chr16:339420..3767509 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.158T>G (p.Met53Arg) single nucleotide variant not provided [RCV004722210] Chr16:2519296 [GRCh38]
Chr16:2569297 [GRCh37]
Chr16:16p13.3
likely pathogenic
NM_001694.4(ATP6V0C):c.350G>A (p.Gly117Asp) single nucleotide variant not provided [RCV004763921]   uncertain significance
NM_001694.4(ATP6V0C):c.385G>A (p.Val129Met) single nucleotide variant not provided [RCV004772753] Chr16:2519662 [GRCh38]
Chr16:2569663 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:2229815-2582030)x4 copy number gain Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome [RCV004767715] Chr16:2229815..2582030 [GRCh37]
Chr16:16p13.3
likely pathogenic
NM_001694.4(ATP6V0C):c.46G>A (p.Val16Ile) single nucleotide variant not provided [RCV004769789] Chr16:2514149 [GRCh38]
Chr16:2564150 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.101C>G (p.Thr34Arg) single nucleotide variant not provided [RCV004771955] Chr16:2519239 [GRCh38]
Chr16:2569240 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 copy number gain not provided [RCV000738917] Chr16:88165..90163275 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3(chr16:2510603-2581022)x3 copy number gain not provided [RCV000751529] Chr16:2510603..2581022 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2516738-2667855)x1 copy number loss not provided [RCV000751531] Chr16:2516738..2667855 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:109978-4316797) copy number gain Chromosome 16p13.3 duplication syndrome [RCV000767731] Chr16:109978..4316797 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.172C>G (p.Pro58Ala) single nucleotide variant not provided [RCV001090245] Chr16:2519310 [GRCh38]
Chr16:2569311 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.467A>T (p.Ter156Leu) single nucleotide variant EPILEPSY, EARLY-ONSET, 3, WITH DEVELOPMENTAL DELAY [RCV003320483]|Seizure [RCV001254940] Chr16:2519744 [GRCh38]
Chr16:2569745 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:85880-5249457)x3 copy number gain not provided [RCV001259749] Chr16:85880..5249457 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.412G>C (p.Ala138Pro) single nucleotide variant not provided [RCV001300995] Chr16:2519689 [GRCh38]
Chr16:2569690 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:1830141-2592737)x3 copy number gain not provided [RCV001827737] Chr16:1830141..2592737 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_256302)_(4852572_?)dup duplication Epilepsy [RCV003113403]|Idiopathic generalized epilepsy [RCV003109446]|Saldino-Mainzer syndrome [RCV003113404] Chr16:256302..4852572 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.80-1G>T single nucleotide variant not provided [RCV004784420] Chr16:2519217 [GRCh38]
Chr16:2569218 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.409T>C (p.Phe137Leu) single nucleotide variant EPILEPSY, EARLY-ONSET, 3, WITH DEVELOPMENTAL DELAY [RCV003320497] Chr16:2519686 [GRCh38]
Chr16:2569687 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.274C>T (p.Gln92Ter) single nucleotide variant not provided [RCV002461711] Chr16:2519551 [GRCh38]
Chr16:2569552 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.55G>T (p.Ala19Ser) single nucleotide variant not specified [RCV004155973] Chr16:2514158 [GRCh38]
Chr16:2564159 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.253A>T (p.Ser85Cys) single nucleotide variant not specified [RCV004154339] Chr16:2519391 [GRCh38]
Chr16:2569392 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.260_263+11del deletion Epilepsy, early-onset, 3, with or without developmental delay [RCV003320501] Chr16:2519398..2519412 [GRCh38]
Chr16:2569399..2569413 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.188G>C (p.Gly63Ala) single nucleotide variant EPILEPSY, EARLY-ONSET, 3, WITH DEVELOPMENTAL DELAY [RCV003320495]|not provided [RCV004765799] Chr16:2519326 [GRCh38]
Chr16:2569327 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.377G>C (p.Arg126Pro) single nucleotide variant Epilepsy, early-onset, 3, with or without developmental delay [RCV003458949] Chr16:2519654 [GRCh38]
Chr16:2569655 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_2550259)_(3154076_?)del deletion Developmental and epileptic encephalopathy, 1 [RCV004582752] Chr16:2550259..3154076 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001694.4(ATP6V0C):c.425G>A (p.Gly142Asp) single nucleotide variant not provided [RCV004590854] Chr16:2519702 [GRCh38]
Chr16:2569703 [GRCh37]
Chr16:16p13.3
likely pathogenic
NM_001694.4(ATP6V0C):c.187G>A (p.Gly63Ser) single nucleotide variant not specified [RCV004680304] Chr16:2519325 [GRCh38]
Chr16:2569326 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_001694.4(ATP6V0C):c.376C>T (p.Arg126Ter) single nucleotide variant Epilepsy, early-onset, 3, with or without developmental delay [RCV004759476]   likely pathogenic
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:1433
Count of miRNA genes:533
Interacting mature miRNAs:574
Transcripts:ENST00000330398, ENST00000564973, ENST00000565223, ENST00000568562
Prediction methods:Microtar, Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
D16S283  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,567,684 - 2,567,776UniSTSGRCh37
Build 36162,507,685 - 2,507,777RGDNCBI36
Celera162,782,622 - 2,782,712RGD
Cytogenetic Map16p13.3UniSTS
HuRef162,493,656 - 2,493,746UniSTS
D16S284  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,544,973 - 2,545,089UniSTSGRCh37
Build 36162,484,974 - 2,485,090RGDNCBI36
Celera162,759,667 - 2,759,783RGD
Cytogenetic Map16p13.3UniSTS
HuRef162,471,066 - 2,471,182UniSTS
D16S3014  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,553,347 - 2,553,472UniSTSGRCh37
Build 36162,493,348 - 2,493,473RGDNCBI36
Celera162,768,041 - 2,768,166RGD
Cytogenetic Map16p13.3UniSTS
HuRef162,479,444 - 2,479,569UniSTS
SHGC-110273  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,567,743 - 2,568,091UniSTSGRCh37
Build 36162,507,744 - 2,508,092RGDNCBI36
Celera162,782,679 - 2,783,027RGD
Cytogenetic Map16p13.3UniSTS
HuRef162,493,713 - 2,494,061UniSTS
RH66407  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,555,422 - 2,555,556UniSTSGRCh37
Build 36162,495,423 - 2,495,557RGDNCBI36
Celera162,770,116 - 2,770,250RGD
Cytogenetic Map16p13.3UniSTS
HuRef162,481,519 - 2,481,653UniSTS
GeneMap99-GB4 RH Map1666.57UniSTS
SHGC-60646  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,553,277 - 2,553,480UniSTSGRCh37
Build 36162,493,278 - 2,493,481RGDNCBI36
Celera162,767,971 - 2,768,174RGD
Cytogenetic Map16p13.3UniSTS
HuRef162,479,374 - 2,479,577UniSTS
GeneMap99-GB4 RH Map1663.86UniSTS
Whitehead-RH Map1621.4UniSTS
RH66735  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,569,981 - 2,570,151UniSTSGRCh37
GRCh37642,695,691 - 42,695,861UniSTSGRCh37
Build 36642,803,669 - 42,803,839RGDNCBI36
Celera644,247,943 - 44,248,113RGD
Celera162,784,917 - 2,785,087UniSTS
Cytogenetic Map6p21.1UniSTS
Cytogenetic Map16p13.3UniSTS
HuRef642,413,915 - 42,414,085UniSTS
HuRef162,495,951 - 2,496,121UniSTS
GeneMap99-GB4 RH Map6149.72UniSTS
NCBI RH Map6652.8UniSTS
SHGC-32888  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,555,604 - 2,555,728UniSTSGRCh37
Build 36162,495,605 - 2,495,729RGDNCBI36
Celera162,770,298 - 2,770,422RGD
Cytogenetic Map16p13.3UniSTS
HuRef162,481,701 - 2,481,825UniSTS
TNG Radiation Hybrid Map161107.0UniSTS
GeneMap99-GB4 RH Map1649.45UniSTS
Whitehead-RH Map1622.4UniSTS
GeneMap99-G3 RH Map162994.0UniSTS
A009J05  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,552,141 - 2,552,313UniSTSGRCh37
Build 36162,492,142 - 2,492,314RGDNCBI36
Celera162,766,835 - 2,767,007RGD
Cytogenetic Map16p13.3UniSTS
HuRef162,478,238 - 2,478,410UniSTS
GeneMap99-GB4 RH Map1642.2UniSTS
RH69157  
Human AssemblyChrPosition (strand)SourceJBrowse
Cytogenetic Map16p13.3UniSTS
GeneMap99-GB4 RH Map1661.74UniSTS


Expression

RNA-SEQ Expression

adipose tissue
alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
entire extraembryonic component
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
renal system
reproductive system
respiratory system
sensory system
1204 2432 2788 2242 4941 1723 2345 4 622 1939 464 2268 7268 6442 52 3707 846 1729 1612 171

Sequence


Ensembl Acc Id: ENST00000330398   ⟹   ENSP00000329757
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl162,513,952 - 2,520,218 (+)Ensembl
Ensembl Acc Id: ENST00000564973   ⟹   ENSP00000454868
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl162,518,999 - 2,520,218 (+)Ensembl
Ensembl Acc Id: ENST00000565223   ⟹   ENSP00000457782
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl162,514,294 - 2,519,920 (+)Ensembl
Ensembl Acc Id: ENST00000568562   ⟹   ENSP00000454597
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl162,513,976 - 2,519,679 (+)Ensembl
RefSeq Acc Id: NM_001198569   ⟹   NP_001185498
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38162,513,726 - 2,520,218 (+)NCBI
GRCh37162,563,727 - 2,570,224 (+)ENTREZGENE
HuRef162,489,699 - 2,496,194 (+)ENTREZGENE
CHM1_1162,563,664 - 2,570,161 (+)NCBI
T2T-CHM13v2.0162,535,856 - 2,542,340 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001694   ⟹   NP_001685
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38162,513,952 - 2,520,218 (+)NCBI
GRCh37162,563,727 - 2,570,224 (+)ENTREZGENE
Build 36162,503,954 - 2,510,220 (+)NCBI Archive
HuRef162,489,699 - 2,496,194 (+)ENTREZGENE
CHM1_1162,563,808 - 2,570,161 (+)NCBI
T2T-CHM13v2.0162,536,082 - 2,542,340 (+)NCBI
Sequence:
RefSeq Acc Id: NP_001185498   ⟸   NM_001198569
- UniProtKB: Q6FH26 (UniProtKB/Swiss-Prot),   P27449 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: NP_001685   ⟸   NM_001694
- UniProtKB: Q6FH26 (UniProtKB/Swiss-Prot),   P27449 (UniProtKB/Swiss-Prot)
- Sequence:
Ensembl Acc Id: ENSP00000454868   ⟸   ENST00000564973
Ensembl Acc Id: ENSP00000457782   ⟸   ENST00000565223
Ensembl Acc Id: ENSP00000454597   ⟸   ENST00000568562
Ensembl Acc Id: ENSP00000329757   ⟸   ENST00000330398
Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P27449-F1-model_v2 AlphaFold P27449 1-155 view protein structure

Promoters
RGD ID:6792816
Promoter ID:HG_KWN:22802
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:CD4+TCell,   CD4+TCell_12Hour,   CD4+TCell_2Hour,   HeLa_S3,   Jurkat,   K562,   Lymphoblastoid,   NB4
Transcripts:OTTHUMT00000250810
Position:
Human AssemblyChrPosition (strand)Source
Build 36162,503,546 - 2,504,087 (+)MPROMDB
RGD ID:6792815
Promoter ID:HG_KWN:22803
Type:Non-CpG
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:Lymphoblastoid
Transcripts:UC002CQO.1
Position:
Human AssemblyChrPosition (strand)Source
Build 36162,508,551 - 2,509,051 (+)MPROMDB
RGD ID:7231043
Promoter ID:EPDNEW_H21266
Type:initiation region
Name:ATP6V0C_2
Description:ATPase H+ transporting V0 subunit c
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_H21267  EPDNEW_H21269  EPDNEW_H21268  
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38162,513,728 - 2,513,788EPDNEW
RGD ID:7231041
Promoter ID:EPDNEW_H21267
Type:initiation region
Name:ATP6V0C_1
Description:ATPase H+ transporting V0 subunit c
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_H21266  EPDNEW_H21269  EPDNEW_H21268  
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38162,513,972 - 2,514,032EPDNEW
RGD ID:7231047
Promoter ID:EPDNEW_H21268
Type:initiation region
Name:ATP6V0C_3
Description:ATPase H+ transporting V0 subunit c
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_H21267  EPDNEW_H21266  EPDNEW_H21269  
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38162,519,636 - 2,519,696EPDNEW
RGD ID:7231045
Promoter ID:EPDNEW_H21269
Type:initiation region
Name:ATP6V0C_4
Description:ATPase H+ transporting V0 subunit c
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_H21267  EPDNEW_H21266  EPDNEW_H21268  
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38162,519,959 - 2,520,019EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:855 AgrOrtholog
COSMIC ATP6V0C COSMIC
Ensembl Genes ENSG00000185883 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Transcript ENST00000330398 ENTREZGENE
  ENST00000330398.9 UniProtKB/Swiss-Prot
  ENST00000564973.1 UniProtKB/TrEMBL
  ENST00000565223.1 UniProtKB/TrEMBL
  ENST00000568562.1 UniProtKB/TrEMBL
Gene3D-CATH 1.20.120.610 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
GTEx ENSG00000185883 GTEx
HGNC ID HGNC:855 ENTREZGENE
Human Proteome Map ATP6V0C Human Proteome Map
InterPro ATPase_proteolipid_c-like_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ATPase_proteolipid_csu UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ATPase_proteolipid_su_C_euk UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  F/V-ATP_Csub_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report hsa:527 UniProtKB/Swiss-Prot
NCBI Gene 527 ENTREZGENE
OMIM 108745 OMIM
PANTHER V-TYPE PROTON ATPASE PROTEOLIPID SUBUNIT UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam ATP-synt_C UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB PA25149 PharmGKB
PRINTS VACATPASE UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP SSF81333 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt H3BMY0_HUMAN UniProtKB/TrEMBL
  H3BNI4_HUMAN UniProtKB/TrEMBL
  P27449 ENTREZGENE
  Q6FH26 ENTREZGENE
  VATL_HUMAN UniProtKB/Swiss-Prot
UniProt Secondary Q6FH26 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-02-16 ATP6V0C  ATPase H+ transporting V0 subunit c  ATP6V0C  ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c  Symbol and/or name change 5135510 APPROVED